365 related articles for article (PubMed ID: 16989025)
1. Topiramate: new indication. Migraine prevention: best avoided.
Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
[TBL] [Abstract][Full Text] [Related]
2. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
3. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
Bussone G; Diener HC; Pfeil J; Schwalen S
Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
[TBL] [Abstract][Full Text] [Related]
4. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
[TBL] [Abstract][Full Text] [Related]
5. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
6. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
Ergun H; Gulmez SE; Tulunay FC
Eur Neurol; 2007; 58(4):215-7. PubMed ID: 17827966
[TBL] [Abstract][Full Text] [Related]
7. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
Brown JS; Rupnow MF; Neumann P; Friedman M; Menzin J
Manag Care Interface; 2006 Dec; 19(12):31-8. PubMed ID: 17274479
[TBL] [Abstract][Full Text] [Related]
9. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
[TBL] [Abstract][Full Text] [Related]
10. Topiramate in migraine prevention: evidence-based medicine from clinical trials.
Silberstein SD
Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548
[TBL] [Abstract][Full Text] [Related]
11. Topiramate for migraine prevention.
Wenzel RG; Schwarz K; Padiyara RS
Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
[TBL] [Abstract][Full Text] [Related]
12. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
Bussone G; Usai S; D'Amico D
Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
14. Topiramate in the prophylactic treatment of migraine in children.
Campistol J; Campos J; Casas C; Herranz JL
J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
[TBL] [Abstract][Full Text] [Related]
15. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
Mei D; Capuano A; Vollono C; Evangelista M; Ferraro D; Tonali P; Di Trapani G
Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
[TBL] [Abstract][Full Text] [Related]
16. Topiramate for migraine prophylaxis.
Drug Ther Bull; 2006 Aug; 44(8):62-4. PubMed ID: 16903488
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
[TBL] [Abstract][Full Text] [Related]
18. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
Dahlöf C; Loder E; Diamond M; Rupnow M; Papadopoulos G; Mao L
Health Qual Life Outcomes; 2007 Oct; 5():56. PubMed ID: 17916258
[TBL] [Abstract][Full Text] [Related]
19. Topiramate in migraine prevention.
Silberstein SD
Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
